(RTTNews) - Abbott (ABT) announced the successful completion of the world's first in-human leadless left bundle branch area pacing procedures using the company's investigational AVEIR Conduction ...
Please provide your email address to receive an email when new articles are posted on . Left bundle branch pacing was achieved for the first time via leadless pacemaker. Implantation failure rate was ...
Abbott (ABT)'s investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for Boston Scientific’s pacemaker leads. The expanded indication ...
Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...
Abbott Laboratories, Inc. ABT has completed the world's first-in-human leadless left bundle branch area pacing (LBBAP) procedures. The landmark procedures were part of the prospective Leadless CSP ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results